Short-term survivors with brain metastases have modest benefits from focal and systemic therapies and remain frequent despite improving treatment landscapeM. Czogalla, Clemens Seidel, Sabine Klagges et al.|Clinical and Translational Radiation Oncology|2025Cited by 2
Hyperglycemia is associated with poor survival in patients with brain metastases treated with radiotherapySoniya Poudyal, Clemens Seidel, Friederike Rothe et al.|Strahlentherapie und Onkologie|2025Cited by 1